Belén Palomares

Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity

Xavier Nadal, Carmen del Río, S. Casano et al. · British Journal of Pharmacology · 2017 · 126 citations · Full text

Medicine, Neuroscience, Pharmacology +14

VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease

Javier Díaz-Alonso, Juan Paraíso‐Luna, Carmen Navarrete et al. · Scientific Reports · 2016 · 78 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor

Concepción García, María Gómez‐Cañas, Sonia Burgaz et al. · Journal of Neuroinflammation · 2018 · 64 citations · Full text

Medicine, Neuroscience, Pharmacology +17

PstS‐1, the 38‐kDa<i><scp>M</scp>ycobacterium tuberculosis</i>Glycoprotein, is an Adhesin, Which Binds the Macrophage Mannose Receptor and Promotes Phagocytosis

Maribel Esparza, Belén Palomares, Tonatiuh García et al. · Scandinavian Journal of Immunology · 2014 · 63 citations

Life Sciences, Immunology, Microbiology +12

Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy

Carmen Navarrete, Francisco J. Carrillo‐Salinas, Belén Palomares et al. · Journal of Neuroinflammation · 2018 · 63 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17